Therefore, identifying whether NAF-1 is a key signaling molecule that affects the characteristics of PCSCs and developing interventions against this key molecule may be of great significance for inhibiting the progression of pancreatic cancer and preventing resistance to chemotherapy. This evidence concerns the gene NAF1 and pancreatic neoplasm.